Your session is about to expire
← Back to Search
Chemotherapy
Multimodal Therapy for Peritoneal Cancer
Phase 2
Waitlist Available
Research Sponsored by Herbert Irving Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Measurable or evaluable disease
No CNS metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well combining surgery, chemotherapy, and radiation therapy works in treating patients with peritoneal cancer.
Who is the study for?
This trial is for adults over 18 with peritoneal cancer, specifically malignant mesothelioma. Participants must have a good performance status, meaning they can carry out daily activities with little to no assistance. They should not be pregnant or nursing and must use contraception if fertile. No recent other cancers (except certain skin cancers or cervical carcinoma in situ), uncontrolled diseases, serious infections, or psychiatric disorders are allowed.Check my eligibility
What is being tested?
The study is testing the effectiveness of combining surgery with chemotherapy and radiation therapy on patients with peritoneal cancer. The chemotherapy drugs will be administered directly into the tumor area after surgery to try to kill more tumor cells when combined with radiation therapy.See study design
What are the potential side effects?
Chemotherapy may cause side effects like nausea, vomiting, hair loss, fatigue, increased risk of infection due to low blood cell counts, and potential damage to organs near the treated area. Radiation therapy might lead to skin irritation at the treatment site and fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer can be measured or seen on tests.
Select...
My cancer has not spread to my brain.
Select...
My bilirubin levels are within normal range.
Select...
My heart is healthy with no symptoms of disease or uncontrolled high blood pressure.
Select...
I am over 18 years old.
Select...
My cancer is confirmed as mesothelioma through a biopsy.
Select...
I can take care of myself but might not be able to do heavy physical work.
Select...
My kidney function is good, with proper creatinine clearance and normal BUN levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Herbert Irving Comprehensive Cancer CenterLead Sponsor
33 Previous Clinical Trials
929 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,153 Total Patients Enrolled
93 Trials studying Mesothelioma
8,655 Patients Enrolled for Mesothelioma
Robert N. Taub, MD, PhDStudy ChairHerbert Irving Comprehensive Cancer Center
6 Previous Clinical Trials
109 Total Patients Enrolled
1 Trials studying Mesothelioma
57 Patients Enrolled for Mesothelioma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not on hormonal therapy for cancer, but may be taking hormones for other conditions like diabetes.I have not had radiotherapy to my abdomen, pelvis, or lower chest.My cancer can be measured or seen on tests.I've had up to 2 chemotherapy treatments, with no more than 1 being intraperitoneal, and it's been over 6 weeks since my last chemotherapy.My cancer has not spread to my brain.My bilirubin levels are within normal range.My heart is healthy with no symptoms of disease or uncontrolled high blood pressure.I am over 18 years old.My cancer is confirmed as mesothelioma through a biopsy.I can take care of myself but might not be able to do heavy physical work.My treatment plan for biologic therapy is not decided.I had surgery for my condition more than a week ago and my disease has come back.My kidney function is good, with proper creatinine clearance and normal BUN levels.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research endeavor require more study participants?
"Per the clinicaltrials.gov database, this investigation is no longer recruiting participants as it was last edited on March 1st 2014. However, at present there are 152 other trials searching for volunteers."
Answered by AI
Has the regulatory body sanctioned this medical intervention?
"Based on our team's assessment, this treatment received a rating of 2 due to the limited data confirming its safety and lack of evidence affirming efficacy."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger